Terms: = Liver cancer AND TG, Thyroglobulin AND Prognosis
32 results:
1. Prediction model of ocular metastasis from primary liver cancer: Machine learning-based development and interpretation study.
Sun JQ; Wu SN; Mou ZL; Wen JY; Wei H; Zou J; Li QJ; Liu ZL; Xu SH; Kang M; Ling Q; Huang H; Chen X; Wang YX; Liao XL; Tan G; Shao Y
Cancer Med; 2023 Oct; 12(20):20482-20496. PubMed ID: 37795569
[TBL] [Abstract] [Full Text] [Related]
2. Levels of pretreatment serum lipids predict responses to PD-1 inhibitor treatment in advanced intrahepatic cholangiocarcinoma.
Yang Z; Zhang D; Sima X; Fu Y; Zeng H; Hu Z; Hou J; Pan Y; Zhang Y; Zhou Z; Chen M; Hu D
Int Immunopharmacol; 2023 Feb; 115():109687. PubMed ID: 36628893
[TBL] [Abstract] [Full Text] [Related]
3. Metabolic Reprogramming and Its Relationship to Survival in Hepatocellular Carcinoma.
Wang Q; Tan Y; Jiang T; Wang X; Li Q; Li Y; Dong L; Liu X; Xu G
Cells; 2022 Mar; 11(7):. PubMed ID: 35406630
[TBL] [Abstract] [Full Text] [Related]
4. Retrospective study of the influence of hypothyroidism on liver function before radioiodine therapy in China: a comparison analysis based on patients with differentiated thyroid cancer.
Ji Y; Zheng W; Meng Z; Wu C; Tan J; Wang R
BMJ Open; 2022 Jan; 12(1):e045562. PubMed ID: 35042702
[TBL] [Abstract] [Full Text] [Related]
5. Transcriptomics based multi-dimensional characterization and drug screen in esophageal squamous cell carcinoma.
Li Y; Xu F; Chen F; Chen Y; Ge D; Zhang S; Lu C
EBioMedicine; 2021 Aug; 70():103510. PubMed ID: 34365093
[TBL] [Abstract] [Full Text] [Related]
6. Development of a Prognostic Factor Index Among Women With HR
Vidal GA; Carter GC; Gilligan AM; Saverno K; Zhu YE; Price GL; DeLuca A; Smyth EN; Rybowski S; Huang YJ; Schwartzberg LS
Clin Breast Cancer; 2021 Aug; 21(4):317-328.e7. PubMed ID: 33678566
[TBL] [Abstract] [Full Text] [Related]
7. Calreticulin promotes EMT in pancreatic cancer via mediating Ca
Sheng W; Wang G; Tang J; Shi X; Cao R; Sun J; Lin YH; Jia C; Chen C; Zhou J; Dong M
J Exp Clin Cancer Res; 2020 Oct; 39(1):209. PubMed ID: 33028359
[TBL] [Abstract] [Full Text] [Related]
8. Unusual metastases from differentiated thyroid cancers: A multicenter study in Korea.
Yoon JH; Jeon MJ; Kim M; Hong AR; Kim HK; Shin DY; Kim BH; Kim WB; Shong YK; Kang HC
PLoS One; 2020; 15(8):e0238207. PubMed ID: 32841270
[TBL] [Abstract] [Full Text] [Related]
9. IL-28B variant as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy.
Terashima T; Honda M; Toyama T; Shimakami T; Shimizu R; Takatori H; Arai K; Kawaguchi K; Kitamura K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S
J Gastroenterol Hepatol; 2020 Oct; 35(10):1813-1820. PubMed ID: 32180251
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic value of serum high-density lipoprotein cholesterol in patients with gallbladder cancer.
Yuan B; Fu J; Yu WL; Fu XH; Qiu YH; Yin L; Zhu B; Zhang YJ
Rev Esp Enferm Dig; 2019 Nov; 111(11):839-845. PubMed ID: 31595756
[TBL] [Abstract] [Full Text] [Related]
11. FBXW10 promotes hepatocarcinogenesis in male patients and mice.
Luo YD; Zhang J; Fang L; Zhu YY; You YM; Zhang CC; Zheng P; Zhang LD; Yin LY; Xia F; Bie P; Xie CM
Carcinogenesis; 2020 Jul; 41(5):689-698. PubMed ID: 31400758
[TBL] [Abstract] [Full Text] [Related]
12. Outcomes and Predictors of Response in Steroid-Refractory Acute Graft-versus-Host Disease.
Rashidi A; DeFor TE; Holtan SG; Blazar BR; Weisdorf DJ; MacMillan ML
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2297-2302. PubMed ID: 31325587
[TBL] [Abstract] [Full Text] [Related]
13. Clinical outcomes and prognostic factors in patients with no less than three distant organ system metastases from differentiated thyroid carcinoma.
Zhang XY; Sun JW; Qiu ZL; Wang Y; Chen XY; Zhao JH; Luo QY
Endocrine; 2019 Nov; 66(2):254-265. PubMed ID: 31317522
[TBL] [Abstract] [Full Text] [Related]
14. Fasting Serum Low-Density Lipoprotein (LDL) Before liver Transplantation Predicts Post-Transplant Survival.
Li X; Gong J; Zhou W; Zhang H; Zheng J; Liang J; Hu B
Med Sci Monit; 2019 Apr; 25():2361-2367. PubMed ID: 30931920
[TBL] [Abstract] [Full Text] [Related]
15. Effect of serum triglyceride level on the prognosis of patients with hepatocellular carcinoma in the absence of cirrhosis.
Liu X; Li M; Wang X; Dang Z; Jiang Y; Wang X; Yang Z
Lipids Health Dis; 2018 Nov; 17(1):248. PubMed ID: 30400953
[TBL] [Abstract] [Full Text] [Related]
16. Caspase polymorphisms and prognosis of hepatocellular carcinoma.
Zhang S; Xiao Q; Shi Z; Yu G; Ma XP; Chen H; Zhang P; Shen S; Sai-Yin HG; Chen TY; Lu PX; Wang NJ; Ren W; Huang P; Xie J; Conran C; Zheng SL; Yu L; Xu J; Jiang DK
PLoS One; 2017; 12(4):e0176802. PubMed ID: 28453560
[TBL] [Abstract] [Full Text] [Related]
17. Transcriptome Analysis of WHV/c-myc Transgenic Mice Implicates Cytochrome P450 Enzyme 17A1 as a Promising Biomarker for Hepatocellular Carcinoma.
Wang F; Huang J; Zhu Z; Ma X; Cao L; Zhang Y; Chen W; Dong Y
Cancer Prev Res (Phila); 2016 Sep; 9(9):739-49. PubMed ID: 27339169
[TBL] [Abstract] [Full Text] [Related]
18. Diagnostic and Prognostic Roles of Serum Osteopontin and Osteopontin Promoter Polymorphisms in Hepatitis B-related Hepatocellular Carcinoma.
Chimparlee N; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Poovorawan Y; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(16):7211-7. PubMed ID: 26514514
[TBL] [Abstract] [Full Text] [Related]
19. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial.
Brose MS; Nutting CM; Jarzab B; Elisei R; Siena S; Bastholt L; de la Fouchardiere C; Pacini F; Paschke R; Shong YK; Sherman SI; Smit JW; Chung J; Kappeler C; Peña C; Molnár I; Schlumberger MJ;
Lancet; 2014 Jul; 384(9940):319-28. PubMed ID: 24768112
[TBL] [Abstract] [Full Text] [Related]
20. Antitumor function of microRNA-122 against hepatocellular carcinoma.
Nakao K; Miyaaki H; Ichikawa T
J Gastroenterol; 2014 Apr; 49(4):589-93. PubMed ID: 24531873
[TBL] [Abstract] [Full Text] [Related]
[Next]
